Desipramine hydrochloride

Desipramine Hydrochloride is a tricyclic antidepressant (TCA) primarily used in the treatment of depression. It is a secondary amine TCA, with its chemical name being 3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-methylpropan-1-amine hydrochloride. Desipramine works by inhibiting the reuptake of norepinephrine and, to a lesser extent, serotonin, thereby increasing their levels in the synaptic cleft and contributing to mood elevation.

Medical Uses

Desipramine hydrochloride is indicated for the treatment of MDD, offering relief from depressive symptoms. It may also be used off-label for conditions such as neuropathic pain, attention deficit hyperactivity disorder (ADHD), and certain anxiety disorders, due to its ability to modulate neurotransmitter levels.

Pharmacology

Mechanism of Action

Desipramine inhibits the reuptake of norepinephrine (noradrenaline) and, to a lesser extent, serotonin (5-HT) into presynaptic nerve terminals. This inhibition increases the concentration of these neurotransmitters in the synaptic cleft, enhancing neurotransmission and leading to an antidepressant effect. Desipramine has a higher affinity for norepinephrine transporters than for serotonin transporters, making it more selective for norepinephrine reuptake inhibition.

Pharmacokinetics

Desipramine is well absorbed from the gastrointestinal tract but undergoes extensive first-pass metabolism, leading to a bioavailability of about 40%. It is extensively metabolized in the liver, primarily through demethylation and hydroxylation, and its metabolites are excreted in urine. The half-life of desipramine ranges from 12 to 24 hours, allowing for once-daily dosing in most cases.

Adverse Effects

Common side effects of desipramine include dry mouth, constipation, urinary retention, blurred vision, dizziness, and weight gain. Due to its anticholinergic effects, it may also cause cognitive impairment, especially in the elderly. Desipramine carries a black box warning regarding the increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder and other psychiatric disorders.

Contraindications

Desipramine is contraindicated in individuals with hypersensitivity to tricyclic antidepressants, recent myocardial infarction, and those undergoing treatment with monoamine oxidase inhibitors (MAOIs). Caution is advised in patients with a history of cardiovascular disease, glaucoma, urinary retention, and seizure disorders.

Interactions

Desipramine's effects can be potentiated by other central nervous system depressants, anticholinergic agents, and substances that inhibit cytochrome P450 enzymes, particularly CYP2D6, which is responsible for its metabolism. Concurrent use with MAOIs can lead to severe hypertensive reactions and is contraindicated.

Dosage and Administration

The dosage of desipramine hydrochloride varies based on the condition being treated, patient response, and tolerability. Treatment typically starts with a low dose, gradually increasing to minimize side effects. For the treatment of depression, the usual adult dose ranges from 100 to 200 mg per day, taken orally in divided doses or as a single dose at bedtime.

Conclusion

Desipramine hydrochloride remains a valuable option for the treatment of depression and certain off-label conditions, despite the development of newer antidepressants with more favorable side effect profiles. Its efficacy in treating depression, particularly in cases where norepinephrine reuptake inhibition is beneficial, makes it an important tool in the pharmacological management of depressive disorders.

‎